Literature DB >> 9529153

Humoral immunity due to long-lived plasma cells.

M K Slifka1, R Antia, J K Whitmire, R Ahmed.   

Abstract

Conventional models suggest that long-term antibody responses are maintained by the continuous differentiation of memory B cells into antibody-secreting plasma cells. This is based on the notion that plasma cells are short-lived and need to be continually replenished by memory B cells. We examined the issue of plasma cell longevity by following the persistence of LCMV-specific antibody and plasma cell numbers after in vivo depletion of memory B cells and by adoptive transfer of virus-specific plasma cells into naive mice. The results show that a substantial fraction of plasma cells can survive and continue to secrete antibody for extended periods of time (>1 year) in the absence of any detectable memory B cells. This study documents the existence of long-lived plasma cells and demonstrates a new mechanism by which humoral immunity is maintained.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529153     DOI: 10.1016/s1074-7613(00)80541-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  434 in total

Review 1.  B-cell memory and the persistence of antibody responses.

Authors:  I C MacLennan; C García de Vinuesa; M Casamayor-Palleja
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

2.  Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.

Authors:  D E Hassett; J Zhang; M Slifka; J L Whitton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.

Authors:  A F Ochsenbein; D D Pinschewer; S Sierro; E Horvath; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

4.  Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.

Authors:  Loren D Erickson; Brigit G Durell; Laura A Vogel; Brian P O'Connor; Marilia Cascalho; Teruhito Yasui; Hitoshi Kikutani; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

Authors:  Mark A Brockman; David M Knipe
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells.

Authors:  F Medina; C Segundo; A Campos-Caro; I Salcedo; A García-Poley; J A Brieva
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

7.  Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.

Authors:  M Youd; C Blickarz; L Woodworth; T Touzjian; A Edling; J Tedstone; M Ruzek; R Tubo; J Kaplan; T Lodie
Journal:  Clin Exp Immunol       Date:  2010-04-29       Impact factor: 4.330

8.  Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs.

Authors:  Sang Taek Kim; Jin-Young Choi; Begona Lainez; Vincent P Schulz; David E Karas; Eric D Baum; Jennifer Setlur; Patrick G Gallagher; Joe Craft
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

9.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

10.  CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentation.

Authors:  Ryan W Nelson; James B McLachlan; Jonathan R Kurtz; Marc K Jenkins
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.